Quest Diagnostics Incorporated issued the following announcement on Jan. 6.
Quest Diagnostics hopes to fulfill critical testing needs with NewbornDx Advanced Sequencing Evaluation – a test that provides a targeted approach to testing in a turnaround time meant for the NICU. Find out more.
http://blog.questdiagnostics.com/2019/07/diagnosing-the-most-vulnerable-patients
Original source can be found here.
Source: Quest Diagnostics Incorporated